Most Recent
The world's largest macadamia grower has launched an appeal of an IP Australia decision that found its logo mark was deceptively similar to US confectionary giant Mars’ trade marks for its flagship candy M&Ms.
Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its "inherently implausible" opposition to the patent.
The Full Federal Court has shot down plumbing company Repipe’s appeal of a decision rejecting its innovation patents for a claimed computer-implemented invention, saying it only addressed issues in business operations rather than improving on computer technology.
Tech company Vehicle Management Systems has come up short in its third attempt to block competitor SARB Management Group's patent application for a magnetic parking overstay detector, with the Full Court rejecting claims that VMS' managing director should have been listed as the device's inventor.
A judge has allowed two a2 Milk trade marks to proceed to registration despite "legitimate uncertainty" created by IP Australia in a long-running intellectual property spat with competitor Lion Dairy & Drinks.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
The Federal Court's decision that artificial intelligence can be listed on a patent application as the inventor has become an outlier, as the UK joins the US in rejecting what has become an international battle to claim AI inventorship.
Graphics design platform Canva has been conditionally granted further time to apply to patent an invention for generating websites, after IP Australia found its US patent attorneys had made an "error or omission" by failing to track expiration dates for registering the patent.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.
US-based chemical and materials technology company Cytec Industries has won its Federal Court challenge to a mining patent application by a unit of Ecolab, with the court finding the claims in the patent lacked support and sufficient disclosure.